Further analysis revealed that MDM2 inhibitors promoted the frequency of CD8+ CD73+ TCF-1+ IFN-γ+ TNF+ T cells and T-cell receptor activation and that isolation of these T cells from mice and transfer to PD-1-treated mice increased survival and activated immune memory against melanoma cells.50 Here, CD8A is linked to melanoma.